Savella Tablet, Film Coated
Product Images NDC 55154-4626

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Savella (NDC 55154-4626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4c015261 22d5 4d64 9c4a 6cfea647f0c1 00

4c015261 22d5 4d64 9c4a 6cfea647f0c1 00
Label for Savella 50 mg film-coated tablets containing milnacipran hydrochloride. The label indicates the package contains approximately 1920 tablets. It includes dispensing instructions, storage conditions, manufacturer Cardinal Health details, and a warning to keep out of reach of children. The product is prescription only.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A line graph showing the percent of patients improved according to percent improvement in pain from baseline. It compares three groups: Placebo (solid red line), Milnacipran 100 mg (dashed blue line), and Milnacipran 200 mg (dashed green line). The x-axis represents percent improvement in pain from baseline, and the y-axis represents the percent of patients improved.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A line graph showing the percent of patients improved plotted against the percent improvement in pain from baseline. The graph compares three groups: Placebo, milnacipran 100 mg, and milnacipran 200 mg, with milnacipran doses showing higher patient improvement percentages than placebo across most pain improvement levels.*
FDA Label Image

Structural Formula (Structuralformula)

Structural Formula (Structuralformula)
Chemical structure of milnacipran hydrochloride, the active ingredient in Savella 50 mg film-coated tablets. The structure shows the molecular arrangement including key functional groups relevant to the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.